HCID 86727498, compound → HCID 86727500, compound
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:11][C:10]([C@@H:13]([C:15]2[CH:16]=[C:17]3[C:26](=[CH:27][C:28]=2[C:29]([CH3:31])=[CH2:30])[O:25][CH2:24][C:23]2[N:18]3[C@H:19]([CH3:33])[C:20](=[O:32])[NH:21][N:22]=2)[CH3:14])([CH3:12])[CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2]>CO.[Pd]>[C:1]([O:5][C:6]([N:8]1[CH2:11][C:10]([C@@H:13]([C:15]2[CH:16]=[C:17]3[C:26](=[CH:27][C:28]=2[CH:29]([CH3:31])[CH3:30])[O:25][CH2:24][C:23]2[N:18]3[C@H:19]([CH3:33])[C:20](=[O:32])[NH:21][N:22]=2)[CH3:14])([CH3:12])[CH2:9]1)=[O:7])([CH3:2])([CH3:3])[CH3:4]Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture of 3-[(R)-1-((R)-7-isopropenyl-4-methyl-3-oxo-2,3,4,10-tetrahydro-9-oxa-1,2,4a-triaza-phenanthren-6-yl)-ethyl]-3-methyl-azetidine-1-carboxylic acid tert-butyl ester (0.0795 g, 0.175 mmol) and 10% Pd/C (0.037 g, 0.035 mmol) in MeOH (10 mL) was stirred under H2 for 1 h at rt. The reaction mixture was filtered, the filtrate was evaporated to dryness and the residue was purified by prep-TLC (eluting with 50% EtOAc in petroleum ether) to give 3-[(R)-1-((R)-7-isopropyl-4-methyl-3-oxo-2,3,4,10-tetrahydro-9-oxa-1,2,4a-triaza-phenanthren-6-yl)-ethyl]-3-methyl-azetidine-1-carboxylic acid tert-butyl ester (0.061 g, 76%) as a solid. LC/MS (Table 1, Method 4) Rt=2.972 min.; MS m/z: 457 [M+H]+. 1H NMR (CDCl3, 400 MHz): δ 8.03 (brs, 1H), 7.00-6.92 (m, 1H), 6.64 (brs, 1H), 4.77-4.70 (m, 1H), 4.65-4.52 (m, 2H), 3.92-3.79 (m, 2H), 3.57-3.51 (m, 1H), 3.45 (m, 1H), 3.30 (m, 1H), 3.23-3.14 (m, 1H), 1.55-1.45 (m, 12H), 1.34-1.24 (m, 12H).
Workup
- filtrationThe reaction mixture was filtered
- customthe filtrate was evaporated to dryness
- customthe residue was purified by prep-TLC (eluting with 50% EtOAc in petroleum ether)
Sources & evidence
- ORD record
- ord-fcd0c8fad39e456b85f55bd8824b1475
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09115151B2
Reaction notes
Loading…